יום שלישי, ח׳ תמוז תשפ״וTuesday, June 23, 2026
Follow Us
The U.S. Food and Drug Administration (FDA) has reported positive results in its Phase 2a trial of an oral insulin capsule produced by Israeli-based Oramed. The drug is for the treatment of Type 2 diabetes. The Phase 2b study will be carried out later this year, and Oramed also plans a Phase 2a study for […]
June 21, 2026 
